SUMMARY Sixteen consecutive patients with renovascular hypertension were treated by transluminal dilatation and observed during 6-39 months (mean 21.8 months). Poststenotic renal artery pressure increased (p < 0.001) and the renal arteries were patent on angiograms taken immediately after dilatation. In 13 patients, angiography was repeated 2-9 months later; at that time the selective renal vein renin ratio had decreased (p < 0.001). At the end of the follow-up, blood pressure was improved or normal in 14 cases. One of the eight patients with atherosclerosis was normotensive without treatment, compared with five of six patients with fibromuscular dysplasia (p < 0.05). The results in two cases with vasculitis are uncertain. The four patients with relapses, one after intimal catheter dissection, were treated successfully by redilatation. Thus, renovascular hypertension can be improved by transluminal dilatation in patients with atherosclerosis and in patients with fibromuscular dysplasia with lasting success and a low morbidity rate.
THE APPLICATION of percutaneous transluminal dilatation in patients with renovascular hypertension is the most recent use for this method, which was initially used in peripheral and then in coronary arteries.'-" Although the initial results and the data from short-term follow-up studies are encouraging,2 3, 6-15 the beneficial effects should be shown to be persistent before propagating the method further. We report our experience in 16 consecutive cases, including patients with atherosclerosis, fibromuscular dysplasia (FMD) and vasculitis, observed for 6-39 months.
Patients and Methods

Patient Evaluation
Nineteen stenosed renal arteries were treated by transluminal dilatation in a group of 16 consecutive patients (table 1) . Eight patients had renal artery stenosis regarded by radiologic criteria"6' 17 as due to atherosclerosis; in one (patient 7), this was found in three renal arteries. Six other patients showed angiographic signs of FMD, in one case the intimal and in five the medial type of FMD. Systemic vasculitis was suspected in two patients: in one man because of multilocular vascular lesions, including bilateral renal artery stenoses, the histologic aspect of a popliteal artery biopsy and a high erythrocyte sedimentation rate, and in one woman because of progressive bilateral renal artery stenosis, associated with lupus erythematosus discoides. Only case 15, who had vasculitis, was treated systemically (prednisone 30 mg/day).
In all patients, renal vein renin was determined by radioimmunoassay. 18 Selective renal vein blood samples were taken before and after dilatation after renin stimulation by daily ingestion of furosemide (120 mg) given 3 days before the examination. Betablocking drugs were discontinued for at least 2 weeks. Ischemic/contralateral kidney renin ratios ranged from 1.56-3.35 before dilatation.
The patients were examined before and immediately after dilatation and every 3 months thereafter. In 13 patients, renal arteriography and selective renal vein renin determinations were repeated 2-9 months after dilatation. In patients 3, 4 and 14, no late followup angiograms were performed. The patients were classified as either cured, when they were normotensive (150/90 mm Hg or less) without antihypertensive treatment, or as improved, when systolic and diastolic pressures were at least 15% lower than control or in the normal range while under constant or reduced antihypertensive therapy.7 ' 14, 17, 19 The follow-up blood pressures were compared with control values by using a paired t test after a one-way analysis of variance; renin ratio and renal artery pressure were compared by using a paired t test, and the cure rates by applying a chi-square test in a 3 X 2 contingency table.
Transluminal Dilatation
We used a coaxial catheter system2-4, 16 inserted percutaneously through the femoral or, in one instance, through the axillary artery. In 15 patients the intervention was done under local and in one under general anesthesia. The system consists of a curved catheter (2.7-mm o.d.), guiding an insertable dilatation catheter to the orifice of the renal artery. The dilatation catheter carries a preshaped, inelastic balloon segment (5-mm diameter in inflated state, 12 mm long) approximately 10 mm from the tip, that can be inflated through one of the two lumens with a pressure of 5-6 atm (500-600 kPa). Through the other lumen ISignificantly different from the group with AS (p < 0.05).
Abbreviations: AS = atherosclerosis; FMD = fibromuscular dysplasia; L = left; R = right; Dilat. = transluminal dilatation; Creat. = serum creatinine; BP = blood pressure.
of the dilatation catheter, either contrast material may be injected to ascertain the correct position of the catheter tip or blood pressure in the poststenotic renal artery may be measured before and after dilatation.
To perform the dilatation, the balloon segment of the catheter is placed under fluoroscopic control at the site of the stenosis. The balloon is inflated for approximately 5 seconds under manometric control by hand or with a pressure pump with diluted contrast media. After the first or repeated inflation, blood pressure measurements distal to the stenosis were made through the terminal orifice. In most instances, a sep- Figure 4 shows the renal vein renin ratio before dilatation. It tion was done in 13 patients an average of 4.5 months after dilatation. Only the three patients in whom a relapse was suspected on the angiographic and clinical findings had an elevated value. In patients 4 and 8, in A whom renin determinations were done 30-60 minutes after dilatation, the values were normalized. The creatinine values before dilatation had not changed significantly on the average 1 or 6 months after dilata- cluded and the contralateral artery recently performed. Discussion Extended experience with surgery in patients with renovascular hypertension has been acquired. Although the results in some studies are remarkably good, nephrectomies and reoperations are not infrequent, and mortality ranges from 1_9%.111-23 It is too early to compare the results of transluminal dilatation conclusively, but similar prognostic conclusions emerge for dilatation as for surgery. Patients with atherosclerosis and those with FMD may profit from dilatation.
The patients with FMD in our study have a significantly better chance of being improved or cured compared with the patients with atherosclerosis, perhaps because they are younger and do not have generalized vascular disease ( Echophonocardiographic records of 100 patients with congestive cardiomyopathy were reviewed for evidence of pulsus alternans. We found persistent alternans in 10 patients and VPC-induced alternans in seven patients. We could not measure any difference in severity of disease in patients with pulsus alternans compared with those without. PULSUS ALTERNANS was first described by Traube more than a century ago.' Although hemodynamic studies have been made in humans2-12 and efforts to reproduce the condition have been undertaken,'8-'" its physiologic mechanism is uncertain; nor has its incidence been determined in the deteriorated forms of heart disease in which it is considered to be a useful diagnostic sign. Pulsus alternans is ordinarily recognized from the carotid and peripheral pulse or blood pressure, but hemodynamic studies have revealed its presence in the pulmonary circulation as well.5, [16] [17] [18] [19] Echocardiography provides a means of observing intracardiac structures continuously and noninvasively. The presence of pulsus alternans can thus be determined by timing semilunar valve movements. 20' 21 This method can be applied to both rightand left-sided events. 20 Right-sided pulsus alternans may be observed by other noninvasive methods, such as external registration of pulmonary arterial pulsations, but this method is impractical.22
The only reliable method available for determining bilateral alternation has been the simultaneous recording of pressures or flow velocity from the systemic and pulmonary circulations."' 8, 28 These invasive methods are unsuitable for observations under physiologic conditions or for repeated observations in the same patient. The development in our laboratory of dual echocardiography,24 permitting the registration of Mmode echograms from two intracardiac structures, has lowed recording both semilunar valves simultaneously. This method is ideal for determining the presence of symmetrical or asymmetrical pulsus alternans.
Pulsus alternans is a characteristic feature of severe ventricular dysfunction, but its incidence is unknown. Using the computerized recording and retrieval system that has been used in our laboratory for 7 years, we can identify and study the records of a large number of patients with congestive cardiomyopathy and determine the prevalence of pulsus alternans.
Materials and Methods
Definition
Pulsus alternans is a beat-to-beat alternation of strong and weak contractions without significant 617
